title: Effect Of Catheter Ablation On Quality Of Life In Atrial Fibrillation.
abstract: Atrial fibrillation (AF) is the most common sustained arrhythmia seen in clinical practice, affecting approximately 1% of the overall population. While rarely life-threatening, AF is almost universally associated with increased morbidity and mortality, predominantly through an increased risk of thromboembolic events, left ventricular dysfunction, as well as significant impairments in functional capacity and health-related quality of life (HRQOL).[1-8] Improvement in HRQOL, with a secondary reduction of disability and health-care resource utilization, is one of the major therapeutic goals in the management of AF.
authors.affiliation: The Electrophysiology Service at the Montreal Heart Institute and the Department of Medicine, Université de Montréal, Montreal, Canada.
authors.forename: Jorge
authors.initials: J
authors.lastname: Gonzalez
authors.affiliation: The Electrophysiology Service at the Montreal Heart Institute and the Department of Medicine, Université de Montréal, Montreal, Canada.
authors.forename: Laurent
authors.initials: L
authors.lastname: Macle
authors.affiliation: The Department of Medicine, The University of British Columbia, British Columbia, Canada.
authors.forename: Marc W
authors.initials: MW
authors.lastname: Deyell
authors.affiliation: The Department of Medicine, The University of British Columbia, British Columbia, Canada.
authors.forename: Matthew T
authors.initials: MT
authors.lastname: Bennett
authors.affiliation: The Electrophysiology Service at the Montreal Heart Institute and the Department of Medicine, Université de Montréal, Montreal, Canada.
authors.forename: Marc
authors.initials: M
authors.lastname: Dubuc
authors.affiliation: The Electrophysiology Service at the Montreal Heart Institute and the Department of Medicine, Université de Montréal, Montreal, Canada.
authors.forename: Katia
authors.initials: K
authors.lastname: Dyrda
authors.affiliation: The Electrophysiology Service at the Montreal Heart Institute and the Department of Medicine, Université de Montréal, Montreal, Canada.
authors.forename: Peter G
authors.initials: PG
authors.lastname: Guerra
authors.affiliation: The Electrophysiology Service at the Montreal Heart Institute and the Department of Medicine, Université de Montréal, Montreal, Canada.
authors.forename: Paul
authors.initials: P
authors.lastname: Khairy
authors.affiliation: The Electrophysiology Service at the Montreal Heart Institute and the Department of Medicine, Université de Montréal, Montreal, Canada.
authors.forename: Blandine
authors.initials: B
authors.lastname: Mondesert
authors.affiliation: The Electrophysiology Service at the Montreal Heart Institute and the Department of Medicine, Université de Montréal, Montreal, Canada.
authors.forename: Léna
authors.initials: L
authors.lastname: Rivard
authors.affiliation: The Electrophysiology Service at the Montreal Heart Institute and the Department of Medicine, Université de Montréal, Montreal, Canada.
authors.forename: Denis
authors.initials: D
authors.lastname: Roy
authors.affiliation: The Electrophysiology Service at the Montreal Heart Institute and the Department of Medicine, Université de Montréal, Montreal, Canada.
authors.forename: Mario
authors.initials: M
authors.lastname: Talajic
authors.affiliation: The Electrophysiology Service at the Montreal Heart Institute and the Department of Medicine, Université de Montréal, Montreal, Canada.
authors.forename: Bernard
authors.initials: B
authors.lastname: Thibault
authors.affiliation: The Electrophysiology Service at the Montreal Heart Institute and the Department of Medicine, Université de Montréal, Montreal, Canada; The Department of Medicine, The University of British Columbia, British Columbia, Canada.
authors.forename: Jason G
authors.initials: JG
authors.lastname: Andrade
keywords: Ablation/ICD/Surgery; Arrhythmias; Clinical Electrophysiology; Drugs; Electrophysiology